Colossal
CompanyColossal Secures $200M in Series C Funding From TWG Global on the Back of Numerous World’s First Scientific Breakthroughs on Path to De-Extinction
Funding allows for expansion of labs, teams, and additional species candidates for de-extinction
DALLAS–(BUSINESS WIRE)–Colossal Biosciences, the world’s first de-extinction company, has today announced $200M in
Date
Jan 15, 2025
Category
biotech
Lead investor
TWG Global
Stage
Series C
Size
$200M
Felicis
Emblem
Dragonfly
Khosla Ventures
Benchmark
Lowercarbon Capital
Accel
Drive Capital
General Catalyst
Touring Capital
Tribe Capital